Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...

The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Patients visiting clinics across multiple hospitals are facing severe difficulties due to an insufficient supply of insulin, ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections, ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.